Literature DB >> 9617791

Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophrenia.

D Longson1, J F Deakin, F M Benes.   

Abstract

Gluatamtergic fibers have been immunocytochemically localized in the entorhinal cortex of postmortem schizophrenic brains. The density of small caliber vertical fibers was higher in schizophrenics than controls, with no significant increase in the number of large caliber fibers. Increased glutamatergic fiber density has been previously reported in the cingulate cortex. It is proposed that increases in glutamatergic fibers from the amygdala may be responsible for these changes and that they may play a central role in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9617791     DOI: 10.1007/BF01276423

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  14 in total

1.  Heterogeneity of layer II neurons in human entorhinal cortex.

Authors:  M J Beall; D A Lewis
Journal:  J Comp Neurol       Date:  1992-07-08       Impact factor: 3.215

2.  Cell loss in the hippocampus of schizophrenics.

Authors:  P Falkai; B Bogerts
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

3.  Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics.

Authors:  F M Benes; J Davidson; E D Bird
Journal:  Arch Gen Psychiatry       Date:  1986-01

Review 4.  Organization of the entorhinal-hippocampal system: a review of current anatomical data.

Authors:  M P Witter
Journal:  Hippocampus       Date:  1993       Impact factor: 3.899

5.  An improved approach to prepare human brains for research.

Authors:  J P Vonsattel; H Aizawa; P Ge; M DiFiglia; A C McKee; M MacDonald; J F Gusella; G B Landwehrmeyer; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1995-01       Impact factor: 3.685

6.  Co-localization of glutamate and tubulin in putative excitatory neurons of the hippocampus and amygdala: an immunohistochemical study using monoclonal antibodies.

Authors:  A J McDonald; A J Beitz; A A Larson; R Kuriyama; C Sellitto; J E Madl
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

7.  Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.

Authors:  B Bogerts; E Meertz; R Schönfeldt-Bausch
Journal:  Arch Gen Psychiatry       Date:  1985-08

8.  Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia.

Authors:  G P Reynolds
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

9.  Prenatal developmental disturbances in the limbic allocortex in schizophrenics.

Authors:  H Jakob; H Beckmann
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

10.  Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.

Authors:  J S Kim; H H Kornhuber; W Schmid-Burgk; B Holzmüller
Journal:  Neurosci Lett       Date:  1980-12       Impact factor: 3.046

View more
  10 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 2.  Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms.

Authors:  Francine M Benes
Journal:  Schizophr Bull       Date:  2007-06-16       Impact factor: 9.306

Review 3.  Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.

Authors:  Alex Fornito; Murat Yücel; Brian Dean; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2008-04-23       Impact factor: 9.306

Review 4.  Extracellular matrix abnormalities in schizophrenia.

Authors:  Sabina Berretta
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

5.  Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.

Authors:  Harry Pantazopoulos; Nicholas Lange; Ross J Baldessarini; Sabina Berretta
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

6.  Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia.

Authors:  Harry Pantazopoulos; Tsung-Ung W Woo; Maribel P Lim; Nicholas Lange; Sabina Berretta
Journal:  Arch Gen Psychiatry       Date:  2010-02

7.  Total number, distribution, and phenotype of cells expressing chondroitin sulfate proteoglycans in the normal human amygdala.

Authors:  Harry Pantazopoulos; Elisabeth A Murray; Sabina Berretta
Journal:  Brain Res       Date:  2008-03-04       Impact factor: 3.252

Review 8.  Amygdalocortical circuitry in schizophrenia: from circuits to molecules.

Authors:  Francine M Benes
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Neural models of schizophrenia.

Authors:  S Heckers
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

10.  Developmental decrease of entorhinal-hippocampal communication in immune-challenged DISC1 knockdown mice.

Authors:  Xiaxia Xu; Lingzhen Song; Rebecca Kringel; Ileana L Hanganu-Opatz
Journal:  Nat Commun       Date:  2021-11-23       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.